RU93045704A - PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENT - Google Patents
PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENTInfo
- Publication number
- RU93045704A RU93045704A RU93045704/14A RU93045704A RU93045704A RU 93045704 A RU93045704 A RU 93045704A RU 93045704/14 A RU93045704/14 A RU 93045704/14A RU 93045704 A RU93045704 A RU 93045704A RU 93045704 A RU93045704 A RU 93045704A
- Authority
- RU
- Russia
- Prior art keywords
- lysinchlonixinate
- analgesis
- producing
- application
- inflammatory agent
- Prior art date
Links
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 229940121363 anti-inflammatory agents Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000007901 soft capsule Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000007903 gelatin capsule Substances 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N Propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003110 anti-inflammatory Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93045704A RU2108787C1 (en) | 1993-09-01 | 1993-09-01 | Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93045704A RU2108787C1 (en) | 1993-09-01 | 1993-09-01 | Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93045704A true RU93045704A (en) | 1996-11-10 |
RU2108787C1 RU2108787C1 (en) | 1998-04-20 |
Family
ID=20147697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93045704A RU2108787C1 (en) | 1993-09-01 | 1993-09-01 | Pharmaceutical soft capsules containing lysinchlonixinate, method of their preparing |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2108787C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130009553A (en) * | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | Capsule formulation comprising montelukast or a pharmaceutically acceptable salt thereof, and levocetirizine or a pharmaceutically acceptable salt thereof |
-
1993
- 1993-09-01 RU RU93045704A patent/RU2108787C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2168732A1 (en) | Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution | |
ATE65023T1 (en) | PHARMACEUTICAL AGENT. | |
CA2164933A1 (en) | Methods for Aiding Periodontal Tissue Regeneration | |
CA2232310A1 (en) | Stable compositions containing n-propargyl-1-aminoindan | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
CA2320039A1 (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
DE3872199D1 (en) | PHARMACEUTICAL COMPOSITIONS. | |
EP0382066A3 (en) | Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent | |
CY1106542T1 (en) | METHOD OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATINE PRESCRIPTIONS | |
DE69321596T2 (en) | ESTERS AND COMBINATIONS OF AN ORGANIC NITRATE AND A SALICYCLATE | |
FI870457A0 (en) | PHARMACEUTICAL FORM FOR STABILIZATION OF THE INTERFERENCE. | |
ITMI913170A1 (en) | PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE CONTAINING A NON-STEROID ANTI-INFLAMMATORY AND A DECONGESTANT AS ACTIVE INGREDIENTS | |
ATE253354T1 (en) | CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE | |
ES2039377T3 (en) | A SUPPOSITORY. | |
RU93045704A (en) | PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINCHLONIXINATE, METHOD FOR PRODUCING THEREOF, APPLICATION AS AN ANALGESIS AND / OR ANTI-INFLAMMATORY AGENT | |
WO1999008666A3 (en) | Pharmaceutical composition comprising an azateroid | |
UA40636C2 (en) | pharmaceutical composition containing, as the active ingredient, an association of acetylsalicylic acid and metoclopramide, pharmaceutical medication in the form of powder and method for its preparation | |
EP0351897A3 (en) | Skin penetration system for salts of amine-functional drugs | |
JPS5750914A (en) | Betamethasone external pharmaceutical | |
ATE136778T1 (en) | ORAL MEDICINAL PRODUCTS CONTAINING DAPIPRAZOLE | |
RU93004785A (en) | SOLID CAPSULES OF CITARABIN OXPHOSPHATE | |
CA2182812A1 (en) | Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide | |
KR940000108A (en) | Pharmacological soft capsules containing lysine clonicsinate and method for preparing the same | |
KR960003717A (en) | Use of elliprodil and its enantiomers for the manufacture of a medicament useful for the prevention of peripheral neuropathy caused by anticancer agents | |
FR2547730B1 (en) | HYPOLIPIDEMIC DRUG CONTAINING AS ACTIVE INGREDIENT D-3-ACETOXY-CIS-2,3-DIHYDRO-5- (2- (DIMETHYLAMINO) ETHYL) -2- (P-METHOXYPHENYL) -1,5-BENZOTHIAZEPINE-4 (5H) -ONE OR ONE OF ITS SALTS OF ADDITION OF ACIDS ACCEPTABLE IN PHARMACY |